← Back to headlines
Celldex Presents Barzolvolimab Data at Cantor Conference
Biotech company Celldex presented new clinical data for barzolvolimab at the Cantor conference, highlighting potential developments in its oncology pipeline.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
